We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-1.29%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$3.39B
AUM Growth
+$526M
Cap. Flow
+$586M
Cap. Flow %
17.28%
Top 10 Hldgs %
16.92%
Holding
1,543
New
205
Increased
822
Reduced
368
Closed
82
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWE
801
DELISTED
World Wrestling Entertainment
WWE
$529K 0.02%
+38,410
New +$521K
JTP
802
DELISTED
NUVEEN QUALITY PFD INCOME FD
JTP
$529K 0.02%
64,938
+2,378
+4% +$19.8K
PCL
803
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$529K 0.02%
13,557
+427
+3% +$17.8K
FDS icon
804
Factset
FDS
$10.2B
$523K 0.02%
4,306
+948
+28% +$117K
CHW
805
Calamos Global Dynamic Income Fund
CHW
$555M
$522K 0.02%
56,273
+6,872
+14% +$65.8K
FLY
806
DELISTED
Fly Leasing Limited
FLY
$522K 0.02%
40,718
APD icon
807
Air Products & Chemicals
APD
$68B
$521K 0.02%
4,328
-11
-0.3% -$1.34K
TPR icon
808
Tapestry
TPR
$25.9B
$519K 0.02%
14,564
+1,704
+13% +$61K
WT icon
809
WisdomTree
WT
$3.44B
$519K 0.02%
45,579
-377
-0.8% -$4.29K
CEM
810
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
$517K 0.02%
3,711
-98
-3% -$14.1K
ERIE icon
811
Erie Indemnity
ERIE
$13.4B
$516K 0.02%
6,809
+2,674
+65% +$201K
CME icon
812
CME Group
CME
$96.1B
$515K 0.02%
6,437
+322
+5% +$24.3K
FLR icon
813
Fluor
FLR
$7B
$515K 0.02%
7,713
+1,117
+17% +$82.2K
PEY icon
814
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.18B
$515K 0.02%
41,351
+4,939
+14% +$62.3K
HRB icon
815
H&R Block
HRB
$6.76B
$512K 0.02%
16,525
+671
+4% +$21.9K
OPPJ
816
WisdomTree Trust WisdomTree Japan Opportunities Fund
OPPJ
$290M
$511K 0.02%
+32,328
New +$499K
CNI icon
817
Canadian National Railway
CNI
$77.2B
$510K 0.02%
7,181
+1,745
+32% +$121K
STH
818
DELISTED
SABRIENT STEALTH PRT CLAYMORE EXCH TRD FD
STH
$510K 0.02%
19,751
-1,405
-7% -$36.3K
CPB icon
819
Campbell Soup
CPB
$6.94B
$507K 0.01%
11,867
-30
-0.3% -$1.31K
X
820
DELISTED
US Steel
X
$506K 0.01%
12,928
-2,643
-17% -$92.6K
ITC
821
DELISTED
ITC HOLDINGS CORP
ITC
$504K 0.01%
14,141
+212
+2% +$7.71K
PFG icon
822
Principal Financial Group
PFG
$24.6B
$503K 0.01%
9,594
+3,208
+50% +$168K
XPH icon
823
State Street SPDR S&P Pharmaceuticals ETF
XPH
$511M
$503K 0.01%
9,498
+474
+5% +$24.1K
PFN
824
PIMCO Income Strategy Fund II
PFN
$699M
$502K 0.01%
47,644
-11,981
-20% -$129K
DNOW icon
825
DNOW Inc
DNOW
$2.95B
$501K 0.01%
+16,469
New +$539K

Similar funds

Cambridge Investment Research Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Cambridge Investment Research Advisors held 1,543 positions worth $3.39B, up 18% from $2.87B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Cambridge Investment Research Advisors deployed $586M of net new capital in Q3 2014, opening 205 new positions and adding to 822 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 556,997 shares worth $101M.

By sector, the portfolio is most concentrated in Energy at 5.4% of assets, down from 6.5% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares Russell 3000 ETF, an estimated $20M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2014 buy was Vanguard S&P 500 ETF: 556,997 shares worth $101M.
  • Cambridge Investment Research Advisors added most to Barclays Bank Plc in Q3 2014, an estimated $45.8M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2014 reduction was iShares Russell 3000 ETF, cutting an estimated $20M.
  • Cambridge Investment Research Advisors fully exited iShares MSCI Taiwan ETF in Q3 2014, selling an estimated $1.83M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $3.39B portfolio in Q3 2014.
  • Cambridge Investment Research Advisors opened 205 new positions and closed 82 in Q3 2014.
  • Cambridge Investment Research Advisors's portfolio value rose 18% quarter-over-quarter to $3.39B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2014, filed 5 Nov 2014.